These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Genetically based therapeutics for cancer: similarities and contrasts with traditional drug discovery and development. Hermiston TW; Kirn DH Mol Ther; 2005 Apr; 11(4):496-507. PubMed ID: 15771953 [TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody therapeutics and apoptosis. Ludwig DL; Pereira DS; Zhu Z; Hicklin DJ; Bohlen P Oncogene; 2003 Dec; 22(56):9097-106. PubMed ID: 14663488 [TBL] [Abstract][Full Text] [Related]
8. [Pharmacologic characteristics and clinical activity of human rituximab anti-CD20 monoclonal antibody]. Varaldo R; Gobbi M Ann Ital Med Int; 2003; 18(3):182-7. PubMed ID: 14621431 [No Abstract] [Full Text] [Related]
9. Intracellular delivery of oligonucleotide conjugates and dendrimer complexes. Juliano RL Ann N Y Acad Sci; 2006 Oct; 1082():18-26. PubMed ID: 17145920 [TBL] [Abstract][Full Text] [Related]
10. Peptide-oligonucleotide conjugates form stable and selective complexes with antibody and DNA. Tennilä T; Antopolsky M; Azhayev A; Azhayeva E Bioconjug Chem; 2008 Jul; 19(7):1361-7. PubMed ID: 18529023 [TBL] [Abstract][Full Text] [Related]
11. Silencing human genetic diseases with oligonucleotide-based therapies. Martínez T; Wright N; López-Fraga M; Jiménez AI; Pañeda C Hum Genet; 2013 May; 132(5):481-93. PubMed ID: 23494242 [TBL] [Abstract][Full Text] [Related]
12. [A novel paradigm and new targets in cancer therapy]. Novik AA; Kamilova TA; Tsygan VN Vopr Onkol; 2003; 49(6):695-704. PubMed ID: 14976912 [No Abstract] [Full Text] [Related]